prosetta.comHealthcareFounded: 1900Funding to Date: $40.04MM
Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).
View Enterprise Value for Prosetta Biosciences.